SOVEPTUS Trademark Information

Trademark by Glaxo Group Limited

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncolog...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: SOVEPTUS
Status/Status Date:
REGISTERED
4/26/2016
Estimated Renewal Deadline: April 26, 2022
Serial Number: 86703950
Filing Date: 7/24/2015
Registration Number: 4945011
Registration Date: 4/26/2016
Goods and Services: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 2/9/2016
Last Applicant/Owner:
Glaxo Group Limited
Brentford, Middlesex TW89GS
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
GLAXOSMITHKLINE
5 MOORE DRIVE, LGTM, 5.5A
RESEARCH TRIANGLE PARK, NC 27709
Current Status:
REGISTERED
4/26/2016
Correspondent Search:
CHRISTOPHER M. HANES is a correspondent of SOVEPTUS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on